SCHEMBL25752933

SCHEMBL25752933

c1ccc(-c2cccc([Si](c3cccc(-c4ccccc4)c3)(c3cccc(-c4ccccc4)c3)c3cccc(-c4cc(-c5cccc(-n6c7ccccc7c7ccccc76)c5)nc(-n5c6ccccc6c6ccccc65)n4)c3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
ATM Q13315 2/20 0.41
PDE10A Q9Y233 1/20 0.34
KMT2A Q03164 4/20 0.33
MEN1 O00255 3/20 0.33
TET2 Q6N021 1/20 0.33
TET1 Q8NFU7 1/20 0.33
GAA P10253 1/20 0.33
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
ALDH1A1 P00352 3/20 0.32
HTT P42858 2/20 0.32
FAAH O00519 1/20 0.32
HSP90AA1 P07900 1/20 0.32
PKM P14618 1/20 0.32
MGLL Q99685 1/20 0.32
MAPT P10636 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25752930 0.99 KDM4E (0.40) KDM4EL3MBTL1ATMPDE10AKMT2A
SCHEMBL25752931 0.99 KDM4E (0.40) KDM4EL3MBTL1ATMPDE10AKMT2A
SCHEMBL25752966 0.95 L3MBTL1 (0.37) KDM4EL3MBTL1ATMPDE10AKMT2A
SCHEMBL25752962 0.94 KDM4E (0.36) KDM4EL3MBTL1ATMPDE10AKMT2A
SCHEMBL25752982 0.92 KDM4E (0.34) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL25752981 0.92 KDM4E (0.34) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL25752979 0.92 KDM4E (0.34) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL26375940 0.91 KDM4E (0.34) KDM4EL3MBTL1ATM
SCHEMBL26442558 0.90 KDM4E (0.36) KDM4EL3MBTL1ATMKMT2AMEN1
SCHEMBL22038594 0.89 MAPT (0.38) KDM4EL3MBTL1ATMPDE10AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230217807-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230217807-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, CYP1A1, CYP1B1 KDM4E 2724/4885L3MBTL1 992/4885ATM 3848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.